Literature DB >> 33103450

Holistic characterization of single-hepatocyte transcriptome responses to high-fat diet.

Sung Rye Park1,2, Chun-Seok Cho1, Jingyue Xi2, Hyun Min Kang2, Jun Hee Lee1.   

Abstract

During nutritional overload and obesity, hepatocyte function is grossly altered, and a subset of hepatocytes begins to accumulate fat droplets, leading to nonalcoholic fatty liver disease (NAFLD). Recent single-cell studies revealed how nonparenchymal cells, such as macrophages, hepatic stellate cells, and endothelial cells, heterogeneously respond to NAFLD. However, it remains to be characterized how hepatocytes, the major constituents of the liver, respond to nutritional overload in NAFLD. Here, using droplet-based, single-cell RNA sequencing (Drop-seq), we characterized how the transcriptomic landscape of individual hepatocytes is altered in response to high-fat diet (HFD) and NAFLD. We showed that the entire hepatocyte population undergoes substantial transcriptome changes upon HFD, although the patterns of alteration were highly heterogeneous, with zonation-dependent and -independent effects. Periportal (zone 1) hepatocytes downregulated many zone 1-specific marker genes, whereas a small number of genes mediating gluconeogenesis were upregulated. Pericentral (zone 3) hepatocytes also downregulated many zone 3-specific genes; however, they upregulated several genes that promote HFD-induced fat droplet formation, consistent with findings that zone 3 hepatocytes accumulate more lipid droplets. Zone 3 hepatocytes also upregulated ketogenic pathways as an adaptive mechanism to HFD. Interestingly, many of the top HFD-induced genes, which encode proteins regulating lipid metabolism, were strongly co-expressed with each other in a subset of hepatocytes, producing a variegated pattern of spatial co-localization that is independent of metabolic zonation. In conclusion, our data set provides a useful resource for understanding hepatocellular alteration during NAFLD at single cell level.

Entities:  

Keywords:  HFD; NAFLD; hepatocytes; liver; obesity; scRNA-seq; single cell

Mesh:

Substances:

Year:  2020        PMID: 33103450      PMCID: PMC8260362          DOI: 10.1152/ajpendo.00391.2020

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  54 in total

1.  Hepatocyte-Specific Disruption of CD36 Attenuates Fatty Liver and Improves Insulin Sensitivity in HFD-Fed Mice.

Authors:  Camella G Wilson; Jennifer L Tran; Derek M Erion; Nicholas B Vera; Maria Febbraio; Ethan J Weiss
Journal:  Endocrinology       Date:  2015-12-09       Impact factor: 4.736

2.  ShinyGO: a graphical gene-set enrichment tool for animals and plants.

Authors:  Steven Xijin Ge; Dongmin Jung; Runan Yao
Journal:  Bioinformatics       Date:  2020-04-15       Impact factor: 6.937

3.  The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes.

Authors:  Maria Sörhede Winzell; Bo Ahrén
Journal:  Diabetes       Date:  2004-12       Impact factor: 9.461

4.  Hepatic gene expression profiles in a long-term high-fat diet-induced obesity mouse model.

Authors:  Sujong Kim; Insuk Sohn; Joon-Ik Ahn; Ki-Hwan Lee; Yeon Sook Lee; Yong Sung Lee
Journal:  Gene       Date:  2004-09-29       Impact factor: 3.688

5.  Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity.

Authors:  Debby P Y Koonen; René L Jacobs; Maria Febbraio; Martin E Young; Carrie-Lynn M Soltys; Huy Ong; Dennis E Vance; Jason R B Dyck
Journal:  Diabetes       Date:  2007-08-29       Impact factor: 9.461

6.  Hepatic Dysfunction Caused by Consumption of a High-Fat Diet.

Authors:  Anthony R Soltis; Norman J Kennedy; Xiaofeng Xin; Feng Zhou; Scott B Ficarro; Yoon Sing Yap; Bryan J Matthews; Douglas A Lauffenburger; Forest M White; Jarrod A Marto; Roger J Davis; Ernest Fraenkel
Journal:  Cell Rep       Date:  2017-12-12       Impact factor: 9.423

7.  Seq-Well: portable, low-cost RNA sequencing of single cells at high throughput.

Authors:  Todd M Gierahn; Marc H Wadsworth; Travis K Hughes; Bryan D Bryson; Andrew Butler; Rahul Satija; Sarah Fortune; J Christopher Love; Alex K Shalek
Journal:  Nat Methods       Date:  2017-02-13       Impact factor: 28.547

8.  High fat diet-induced changes of mouse hepatic transcription and enhancer activity can be reversed by subsequent weight loss.

Authors:  Majken Siersbæk; Lyuba Varticovski; Shutong Yang; Songjoon Baek; Ronni Nielsen; Susanne Mandrup; Gordon L Hager; Jay H Chung; Lars Grøntved
Journal:  Sci Rep       Date:  2017-01-10       Impact factor: 4.379

9.  Resolving the fibrotic niche of human liver cirrhosis at single-cell level.

Authors:  P Ramachandran; R Dobie; J R Wilson-Kanamori; E F Dora; B E P Henderson; N T Luu; J R Portman; K P Matchett; M Brice; J A Marwick; R S Taylor; M Efremova; R Vento-Tormo; N O Carragher; T J Kendall; J A Fallowfield; E M Harrison; D J Mole; S J Wigmore; P N Newsome; C J Weston; J P Iredale; F Tacke; J W Pollard; C P Ponting; J C Marioni; S A Teichmann; N C Henderson
Journal:  Nature       Date:  2019-10-09       Impact factor: 49.962

10.  Self-renewing diploid Axin2(+) cells fuel homeostatic renewal of the liver.

Authors:  Bruce Wang; Ludan Zhao; Matt Fish; Catriona Y Logan; Roel Nusse
Journal:  Nature       Date:  2015-08-05       Impact factor: 49.962

View more
  3 in total

1.  Microscopic examination of spatial transcriptome using Seq-Scope.

Authors:  Chun-Seok Cho; Jingyue Xi; Yichen Si; Sung-Rye Park; Jer-En Hsu; Myungjin Kim; Goo Jun; Hyun Min Kang; Jun Hee Lee
Journal:  Cell       Date:  2021-06-10       Impact factor: 66.850

Review 2.  Playing Jekyll and Hyde-The Dual Role of Lipids in Fatty Liver Disease.

Authors:  Martijn R Molenaar; Louis C Penning; J Bernd Helms
Journal:  Cells       Date:  2020-10-06       Impact factor: 6.600

3.  Selective PPARα Modulator Pemafibrate and Sodium-Glucose Cotransporter 2 Inhibitor Tofogliflozin Combination Treatment Improved Histopathology in Experimental Mice Model of Non-Alcoholic Steatohepatitis.

Authors:  Kentaro Murakami; Yusuke Sasaki; Masato Asahiyama; Wataru Yano; Toshiaki Takizawa; Wakana Kamiya; Yoshihiro Matsumura; Motonobu Anai; Tsuyoshi Osawa; Jean-Charles Fruchart; Jamila Fruchart-Najib; Hiroyuki Aburatani; Juro Sakai; Tatsuhiko Kodama; Toshiya Tanaka
Journal:  Cells       Date:  2022-02-18       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.